# Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia

> **NCT07101497** · PHASE2 · RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 60 (estimated)

## Conditions studied

- Menin Inhibitors
- Post Hematopoietic Stem Cell Transplantation
- Maintenance Therapy
- Acute Leukemia
- KMT2A Rearrangement
- NPM1 Mutation
- NUP98 Gene Rearrangement

## Interventions

- **DRUG:** BN104 monotherapy

## Key facts

- **NCT ID:** NCT07101497
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07101497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07101497, "Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07101497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*